Polyrizon partners with Clearmind to develop intranasal MEAI formulation

Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 1.46 -0.16 (9.88%)
Previous Close $1.62    52 Week High
Open $1.56    52 Week Low
Day High $1.56    P/E N/A 
Day Low $1.43    EPS
Volume 329,192       

(NASDAQ: PLRZ) Delayed: 11.26 -2.78 (19.8%)
Previous Close $14.04    52 Week High
Open $13.85    52 Week Low
Day High $13.88    P/E N/A 
Day Low $10.31    EPS
Volume 88,419